ClinicalTrials HQ

Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis

Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis

Enrolling by invitation · NCT07734415 · Registry updated 2026-07-29
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic DermatitisCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorderEnrolling by invitationPhase 22026-07-29NCT07734415

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Inmagene LLC2

23 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Inmagene Site 1LancasterUnited States2
Inmagene Site 10FargoUnited States2
Inmagene Site 11WoodburyUnited States2
Inmagene Site 12AndersonUnited States2
Inmagene Site 13MississaugaCanada2
Inmagene Site 14MontrealCanada2
Inmagene Site 15SurreyCanada2
Inmagene Site 16SaskatoonCanada2
Inmagene Site 17Greater SudburyCanada2
Inmagene Site 18North BayCanada2
Inmagene Site 19OcalaUnited States2
Inmagene Site 2Rolling MeadowsUnited States2
Inmagene Site 20CharlotteUnited States2
Inmagene Site 21New YorkUnited States2
Inmagene Site 22VancouverCanada2
Inmagene Site 23Los AngelesUnited States2
Inmagene Site 3PortlandUnited States2
Inmagene Site 4TampaUnited States2
Inmagene Site 5Mayfield HeightsUnited States2
Inmagene Site 6Kew GardensUnited States2
Inmagene Site 7BurienUnited States2
Inmagene Site 8SouthlakeUnited States2
Inmagene Site 9ColumbusUnited States2